• Skip to main content

Diagnosis: Multiple Sclerosis

Coping with multiple sclerosis symptoms, attacks, and treatments

  • Home
  • About
  • Subscribe
  • What Is MS?
  • Gilenya
  • Contact Us

fingolimod

Diary Of A Gilenya Pioneer: Gilenya Process Speedbumps

February 19, 2011 by Sara

Gilenya Process Speedbumps
Tick Tock, Gilenya, Tick Tock

Almost two weeks ago I posted that  I was in the process of switching to Gilenya. Not so fast, I suppose. My neurologist’s office staff was eager for me to let Gilenya set up all of my doctor appointments for me to undergo the necessary tests. By their accounts they faxed in my information the morning I was in their office, and then a few days later when they hadn’t heard anything back. And then again when I called them after a very unproductive phone call with Gilenya. With such a new drug, I should have expected Gilenya process problems.

Several months ago I switched positions within the company to work in a 24/7 network surveillance group. We rotate weekends, leaving me with a “weekend” during the week for a month here and there. I had hoped that I could use these days to get through all of my doctor appointments this month. But the opportunity to accomplish that is rapidly vanishing.

[Read more…] about Diary Of A Gilenya Pioneer: Gilenya Process Speedbumps

Filed Under: fingolimod, gilenya, insurance, multiple sclerosis, rebif, treatment Tagged With: disease, exacerbation, fingolimod, fty720, gilenya, infection, infusion, injection, interferon, liver, ms, ms attack, multiple sclerosis, neurological disorder, neurologist, novartis, pill, rebif, s1p-receptor modulator, solumedrol

Diary Of A Gilenya Pioneer: Switching To Gilenya!

February 11, 2011 by Sara

Switching To Gilenya
Gilenya (Fingolimod)

As it turns out, similarly to my father’s results with Avonex, Rebif has caused my liver enzymes to shoot up to about 3X the upper limit of normal in the span of slightly less than 2 years. My options?

1) Tysabri : the risk of PML is too severe for me to brave this drug – reputed to be a risk of death or severe disability as high as 1 in 200 for some individuals and 1 in 2000 for others
2) Copaxone : statistically slightly less effective than interferons – works great for my father but I truly don’t want to do a daily injection except as a last resort
3) Gilenya : aka Fingolimod – when this was approved by the FDA I wrote a blog post to summarize all the information I could find – it is the only oral disease modifying drug for Multiple Sclerosis – DING! DING! DING!

I have chosen to switch to Gilenya.

[Read more…] about Diary Of A Gilenya Pioneer: Switching To Gilenya!

Filed Under: fingolimod, gilenya, insurance, liver damage, lymphocyte, macular edema, multiple sclerosis, rebif, treatment, tysabri Tagged With: avonex, betaseron, copaxone, disease, exacerbation, fingolimod, fty720, gilenya, infection, infusion, injection, interferon, liver, ms, ms attack, multiple sclerosis, neurological disorder, neurologist, novartis, pill, pml, rebif, s1p-receptor modulator, solumedrol, tysabri

Gilenya: First Oral Treatment For Multiple Sclerosis

October 20, 2010 by Sara

Gilenya

There has been a huge breakthrough in MS treatment! An oral medication by Novartis, Gilenya (formerly Gingolimod and FTY720), has finally been approved by the FDA to be available by prescription as a daily 0.5 mg capsule as a first line treatment in October.

[Read more…] about Gilenya: First Oral Treatment For Multiple Sclerosis

Filed Under: fingolimod, gilenya, insurance, multiple sclerosis, treatment Tagged With: copaxone, disease, fingolimod, fty720, gilenya, infection, injection, interferon, liver, ms, ms attack, multiple sclerosis, neurological disorder, neurologist, pill, pml, rebif, s1p-receptor modulator, tysabri

Are Neurologists Pushing Tysabri?

May 13, 2010 by Sara

Are Neurologists Pushing Tysabri?
Tysabri : A picture is worth $6900!

It was a dark and stormy night. The hospital corridors were abandoned and echoing with every step. There was a suspicious lack of signage directing individuals to the basement seminar. I had no idea that I had registered for an evening of neurologists pushing Tysabri onto a room full of medicare patients.

My parents assured me that although they’ve gone to many MS events they had never been to a spectacle like this before.

Last night I trekked down to the basement of a hospital branch one county away to attend an MS event my parents had alerted me to called Dialogue of Hope and Health. I can’t deny that I was hoping that the “hope” in the title of the event referred to the new oral medications soon to be available (at least in other countries) or perhaps stem cell developments. It turned out to be something between a sales pitch and damage control conducted by a local neurologist and some Tysabri sales reps.

[Read more…] about Are Neurologists Pushing Tysabri?

Filed Under: clabridine, copaxone, fingolimod, gilenya, insurance, liver damage, multiple sclerosis, rebif, research, treatment, tysabri Tagged With: cladribine, copaxone, disease, fingolimod, gilenya, injection, interferon, ms, ms attack, multiple sclerosis, natalizumab, neurological disorder, neurologist, pill, pml, rebif, tysabri

Oral Drugs For Multiple Sclerosis In 2011

January 21, 2010 by Sara

Oral Drugs For Multiple Sclerosis
Injections hurt!

Finally! Oral disease modifying drugs for Multiple Sclerosis are finally going to be available! I am so glad I make a habit of reading BBC News daily as US news agencies frequently skim over important things in favor of the shocking or violent. Today they published a story about new oral multiple sclerosis treatments that are likely to be available in England in 2011. As someone whose liver does not particularly like Interferon and is afraid of the risk of death from Tysabri infusions this might be a godsend. Since interferons are not available as generics (they contain living organisms and are exempt from status that would let them ever become generic) this could open inexpensive and more successful treatment options to a host of people who have no option but to live with the effects of the disease untreated. I am ecstatic that we finally have oral drugs for Multiple Sclerosis!

The full article and link to it are pasted below, but here is the basic information you want:

  • The oral drugs in question are Fingolimod and Cladribine
  • The drugs are considerably more effective at reducing relapses than current available treatments
  • The drugs may increase your chances of herpes and cancer

[Read more…] about Oral Drugs For Multiple Sclerosis In 2011

Filed Under: clabridine, fingolimod, gilenya, multiple sclerosis, rebif, treatment Tagged With: cladribine, disease, fingolimod, gilenya, interferon, ms, ms attack, multiple sclerosis, neurological disorder, pill, tysabri

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2

Copyright © 2022 · Infinity Pro on Genesis Framework · WordPress · Log in

 

Loading Comments...